As better understanding of AhR activity in breast cancer has shed light on some aspects of AhR signaling, identifying downstream targets will constitute even better option for targeted therapy, given the essential role of AhR in maintenance physiological functions. The gene discussed is AHR; the disease is breast carcinoma.